Aurora, CONCT06320366Now EnrollingIRB Ready

Methamphetamine Use Disorder Clinical Trial in Aurora, CO

Access cutting-edge methamphetamine use disorder treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.

Sponsored by University of Colorado, Denver

Quick Self-Assessment

See if you qualify for this Aurora location

Preparing your pre-screening questions…

Expert Care in Aurora

Access methamphetamine use disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related methamphetamine use disorder treatment provided free

Apply for This Aurora Location

Check if you qualify for this methamphetamine use disorder clinical trial in Aurora, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Aurora

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Aurora site if eligible
  4. 4Begin participation

About This Methamphetamine Use Disorder Study in Aurora

The investigators will evaluate the effects of an accelerated Transcranial Magnetic Stimulation (TMS) protocol of the left dorsolateral prefrontal cortex (DLPFC) for moderate to severe methamphetamine use disorder. This is a randomized parallel group design to assess feasibility and safety, evaluate efficacy (use, craving) and identify magnetic resonance imaging (resting state and cue craving) associated with group/outcomes.

Sponsor: University of Colorado, Denver

Who Can Participate

Inclusion Criteria

Age 21-65 years inclusive;
Meets DSM-5 criteria for past-year moderate or severe methamphetamine use disorder;
By Timeline Follow Back endorses at least 10 days of methamphetamine use out of the last month;
Provides a urine drug screen positive for methamphetamine;
Able to provide informed consent;
No change in current psychiatric medication regimen, or medication free, for at least 4 weeks prior to study entry;
Adequate English proficiency for study consent, and completion of the study instruments.

Exclusion Criteria

Lifetime non-substance-induced psychotic disorders, schizophrenia, schizoaffective disorder or bipolar disorder defined by DSM-5;
Current diagnosis of DSM-5 drug use disorder other than stimulant, cannabis or nicotine use disorder;
Non-substance-induced manic episode within the past 3 years or major depressive episode in the past year;
Current clinically significant neurological disorder or medical illness, including history of seizures, cardiovascular disease/cardiac event, which in the opinion of the study physician would make study participation unsafe;
Presence of a clinically significant abnormality on baseline MRI;
Inability to have an MRI;
Currently breastfeeding, is currently pregnant or lack of use of effective contraception in women of childbearing age, as assessed by urine pregnancy test and self-report (participants will consent to continue effective contraceptives during the study);
Active criminal justice involvement (i.e., any unresolved legal problems that could jeopardize continuation or completion of the study);
History of head injury with loss of consciousness for more than 15 minutes;
Diagnosis of dementia;
Prescribed benzodiazepines or anticonvulsants;
Currently enrolled in formal substance use disorder treatment;
Metal implants or non-removable metal objects above the waist;
Lifetime history of prior clinical treatment with TMS;
Serious risk of suicide or homicide;
Unable/unwilling to follow the study procedures;
History of intractable migraine;
Assessed to be at risk for alcohol or opioid withdrawal.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aurora?

Yes, this clinical trial (NCT06320366) has an active research site in Aurora, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Methamphetamine Use Disorder Treatment Options in Aurora, CO

If you're searching for methamphetamine use disorder treatment options in Aurora, CO, this clinical trial (NCT06320366) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced methamphetamine use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all methamphetamine use disorder clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Aurora, CO

See all heart attack clinical trials recruiting in Aurora — not just this study.

Browse Heart Attack Trials in Aurora →

Browse More Trials by Condition

Heart Attack TrialsEssential Tremor TrialsPulmonary Hypertension TrialsMyocardial Infarction TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Aurora?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Aurora, CO